Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Analysis of Population Pharmacokinetic Data
Testing a Claim about Population Proportion
Hazard Ratio
Odds Ratio
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 7, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Nicholas Moore1, Sinem Ezgi Gulmez, Patrick Blin
1INSERM U657 & CIC-P0005, Univ Bordeaux, Bordeaux, France, nicholas.moore@pharmaco.u-bordeaux2.fr INSERM CIC-P0005, Univ Bordeaux, Bordeaux, France INSERM CIC-P0005, ADERA, Bordeaux, France INSERM U657, Bordeaux, France CHU de Montpellier, Montpellier, France INSERM U657, Rouen, France.
No abstract available in PubMed .